These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24567932)

  • 1. Contrast enhanced ultrasound and magnetic resonance imaging for hepatoma diagnosis.
    Wiwanitkit V
    Med Ultrason; 2014 Mar; 16(1):80. PubMed ID: 24567932
    [No Abstract]   [Full Text] [Related]  

  • 2. Author's response.
    Gheonea IA; Sandulescu L; Saftoiu A
    Med Ultrason; 2014 Mar; 16(1):81-2. PubMed ID: 24707553
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast enhanced ultrasound and magnetic resonance imaging in hepatocellular carcinoma diagnosis.
    Dumitrescu CI; Gheonea IA; Săndulescu L; Surlin V; Săftoiu A; Dumitrescu D
    Med Ultrason; 2013 Dec; 15(4):261-7. PubMed ID: 24286088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
    Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
    Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study].
    Tranquart F; Correas JM; Ladam Marcus V; Manzoni P; Vilgrain V; Aube C; Elmaleh A; Chami L; Claudon M; Cuilleron M; Diris B; Garibaldi F; Lucidarme O; Marion D; Beziat C; Rode A; Tasu JP; Trillaud H; Bleuzen A; Le Gouge A; Giraudeau B; Rusch E
    J Radiol; 2009 Jan; 90(1 Pt 2):109-22. PubMed ID: 19212279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative diagnostic value of computed tomography and contrast-enhanced ultrasonography in diagnosis of focal liver lesions].
    Zviniene K; Zaboriene I; Basevicius A; Pundzius J
    Medicina (Kaunas); 2009; 45(10):751-63. PubMed ID: 19996661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of contrast-enhanced ultrasound in the detection of focal liver leasions.
    Solbiati L; Tonolini M; Cova L; Goldberg SN
    Eur Radiol; 2001; 11 Suppl 3():E15-26. PubMed ID: 11793049
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative diagnostic value of contrast-enhanced ultrasonography, computed tomography, and magnetic resonance imaging in diagnosis of hepatic hemangiomas.
    Zviniene K; Zaboriene I; Basevicius A; Jurkiene N; Barauskas G; Pundzius J
    Medicina (Kaunas); 2010; 46(5):329-35. PubMed ID: 20679748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High correlation between microbubble contrast-enhanced ultrasound, magnetic resonance and histopathology in the evaluation of hepatocellular carcinoma.
    Queiroz MR; Francisco Neto MJ; Garcia RG; Rahal Junior A; Salvalaggio P; Funari MB
    Einstein (Sao Paulo); 2013 Dec; 11(4):500-6. PubMed ID: 24488392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
    Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
    Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: diagnostic criteria by imaging techniques.
    Ronot M; Vilgrain V
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):795-812. PubMed ID: 25260309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hepatocellular carcinoma by contrast enhanced ultrasound: a novel technique.
    Paul SB; Jaganathan S; Hasan A; Dhingra R; Gamanagatti SR; Gupta AK; Acharya SK
    Trop Gastroenterol; 2010; 31(3):213-6. PubMed ID: 21560527
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-arterioportography (US-AP): A new technical approach to perform detection of liver lesions.
    Zorger N; Jung EM; Schreyer AG; Heiss P; Mueller-Wille R; Wiest R; Feuerbach S; Rennert J
    Clin Hemorheol Microcirc; 2010; 46(2-3):117-26. PubMed ID: 21135487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma.
    Hanna RF; Miloushev VZ; Tang A; Finklestone LA; Brejt SZ; Sandhu RS; Santillan CS; Wolfson T; Gamst A; Sirlin CB
    Abdom Radiol (NY); 2016 Jan; 41(1):71-90. PubMed ID: 26830614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.